166 related articles for article (PubMed ID: 18806228)
1. Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.
Linnebank M; Moskau S; Jürgens A; Simon M; Semmler A; Orlopp K; Glasmacher A; Bangard C; Vogt-Schaden M; Urbach H; Schmidt-Wolf IG; Pels H; Schlegel U
Neuro Oncol; 2009 Feb; 11(1):2-8. PubMed ID: 18806228
[TBL] [Abstract][Full Text] [Related]
2. Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma.
Linnebank M; Moskau S; Kowoll A; Semmler A; Bangard C; Vogt-Schaden M; Egerer G; Schackert G; Reichmann H; Schmidt-Wolf IG; Pels H; Schlegel U
Br J Cancer; 2012 Nov; 107(11):1840-3. PubMed ID: 23099805
[TBL] [Abstract][Full Text] [Related]
3. MTX-induced white matter changes are associated with polymorphisms of methionine metabolism.
Linnebank M; Pels H; Kleczar N; Farmand S; Fliessbach K; Urbach H; Orlopp K; Klockgether T; Schmidt-Wolf IG; Schlegel U
Neurology; 2005 Mar; 64(5):912-3. PubMed ID: 15753437
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate.
Choi YJ; Park H; Lee JS; Lee JY; Kim S; Kim TW; Park JS; Kim JE; Yoon DH; Suh C
Hematol Oncol; 2017 Dec; 35(4):504-509. PubMed ID: 27781293
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients?
Salazar J; Moya P; Altés A; Díaz-Torné C; Casademont J; Cerdà-Gabaroi D; Corominas H; Baiget M
Pharmacogenomics; 2014 Jun; 15(8):1079-90. PubMed ID: 25084201
[TBL] [Abstract][Full Text] [Related]
6. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.
Milic V; Jekic B; Lukovic L; Bunjevacki V; Milasin J; Novakovic I; Damnjanovic T; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Pejnovic N; Krajinovic M
Clin Exp Rheumatol; 2012; 30(2):178-83. PubMed ID: 22324981
[TBL] [Abstract][Full Text] [Related]
7. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.
Sala-Icardo L; Lamana A; Ortiz AM; García Lorenzo E; Moreno Fresneda P; García-Vicuña R; González-Álvaro I
Reumatol Clin; 2017; 13(6):318-325. PubMed ID: 27751863
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism.
Semmler A; Moskau-Hartmann S; Stoffel-Wagner B; Elger C; Linnebank M
Clin Chem Lab Med; 2013 Mar; 51(3):665-9. PubMed ID: 23382314
[TBL] [Abstract][Full Text] [Related]
9. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
[TBL] [Abstract][Full Text] [Related]
10. White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab.
Estephan F; Ye X; Dzaye O; Wagner-Johnston N; Swinnen L; Gladstone DE; Ambinder R; Kamson DO; Lambrecht S; Grossman SA; Lin DDM; Holdhoff M
J Neurooncol; 2019 Dec; 145(3):461-466. PubMed ID: 31621040
[TBL] [Abstract][Full Text] [Related]
11. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
Toffoli G; Russo A; Innocenti F; Corona G; Tumolo S; Sartor F; Mini E; Boiocchi M
Int J Cancer; 2003 Jan; 103(3):294-9. PubMed ID: 12471611
[TBL] [Abstract][Full Text] [Related]
12. ATIC Gene Polymorphism and Histologic Response to Chemotherapy in Pediatric Osteosarcoma.
Park JA; Shin HY
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e270-e274. PubMed ID: 28267080
[TBL] [Abstract][Full Text] [Related]
13. Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate.
Becker A; Vezmar S; Linnebank M; Pels H; Bode U; Schlegel U; Jaehde U
Int J Clin Pharmacol Ther; 2007 Sep; 45(9):504-15. PubMed ID: 17907593
[TBL] [Abstract][Full Text] [Related]
14. Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis.
Weisman MH; Furst DE; Park GS; Kremer JM; Smith KM; Wallace DJ; Caldwell JR; Dervieux T
Arthritis Rheum; 2006 Feb; 54(2):607-12. PubMed ID: 16447238
[TBL] [Abstract][Full Text] [Related]
15. Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC
Rheumatol Int; 2016 Nov; 36(11):1591-1599. PubMed ID: 27379764
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of homocysteine metabolism are associated with intracranial aneurysms.
Semmler A; Linnebank M; Krex D; Götz A; Moskau S; Ziegler A; Simon M
Cerebrovasc Dis; 2008; 26(4):425-9. PubMed ID: 18799873
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.
Malik F; Ranganathan P
Pharmacogenomics; 2013 Feb; 14(3):305-14. PubMed ID: 23394392
[TBL] [Abstract][Full Text] [Related]
18. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
Schmeling H; Biber D; Heins S; Horneff G
J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
[TBL] [Abstract][Full Text] [Related]
19. Acute methotrexate-induced encephalopathy--causal relation to homozygous allelic state for MTR c.2756A>G (D919G)?
Linnebank M; Malessa S; Moskau S; Semmler A; Pels H; Klockgether T; Schlegel U
J Chemother; 2007 Aug; 19(4):455-7. PubMed ID: 17855192
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.
Fliessbach K; Helmstaedter C; Urbach H; Althaus A; Pels H; Linnebank M; Juergens A; Glasmacher A; Schmidt-Wolf IG; Klockgether T; Schlegel U
Neurology; 2005 Apr; 64(7):1184-8. PubMed ID: 15824344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
